CAR-T Cell Therapy Market - Global Industry Analysis, Size, Trends, Growth, Trends, and Forecast 2018 - 2028

  • Single User License $3500

CAR-T Cell Therapy Market - Global Industry Analysis, Size, Trends, Growth, Trends, and Forecast 2018 - 2028

Status : August, 2020 | Biotechnology | PPT format

Report Digest


Global CAR-T Cell Therapy Market: Overview

The global CAR-T cell therapy market is set to chart stellar growth owing to an impressive CAGR (Compound Annual Growth Rate) between 2018 and 2028. Multiple factors driving growth in the market, and thus contributing to generation of a plethora of growth opportunities, include increase in incidence of cancer and rising investment in the field of immune oncology.

Thus, it does not come as a surprise that research is being carried out at an intense level and funding is seeing an inflow from both government and pharmaceutical players.  As per WHO, it can be prevented by managing lifestyle such as smoking habits and few other parameters such as exposure to gasoline, radiation, etc. It is noteworthy here that prevention can happen only to a limited extent.

Global CAR-T Cell Therapy Market: Notable Developments

Certain developments happening in the market place are transforming the landscape. Some of these are outlined below.

In 2017, U.S. FDA approved Tisagenlecleucel (Kymriah), CAR-T cell therapy which is historic in its right. It is used for treating ALL (Acute Lymphoblastic Leukemia) in young adults and children. This happened in August and in October of the year, Yescarta for treating refractory or relapsed diffuse large B-cell lymphomas.

In 2018, the same treatment – Kymriah - was approved for another indication. It is diffuse large B-cell Lymphoma. The same year, both treatments were approved in Europe.

The global CAR-T Cell Therapy market is consolidated and highly competitive. Key names in the global CAR-T Cell Therapy market Gilead Sciences, Inc., Bellicum Pharmaceuticals, Inc., Immune Therapeutics, Celgene Corporation, Cellectis, Kite Pharma, Eureka Therapeutics, Juno Therapeutics, Sorrento Therapeutics and Novartis AG among others.

Global CAR T – Cell Therapy Market:  Key trends and driver

The global CAR-T Cell Therapy market is on an upward growth curve owing to various trends and drivers. Some of the prominent ones are outlined below

  • Number of cases of cancer is going up, leading to a need for better therapies. And, this endeavour for reliable and effective approach is set to drive growth in global CAR-T cell therapy market. It might be pertinent to point out here that the number of patients reporting failure to certain therapies is also leading the global CAR-T cell therapy market onto a higher growth trajectory.
  • As a larger number of population is suffering from cancer, governments as well as pharmaceutical players are scurrying to improve outcomes, thereby, grabbing a large chunk of global CAR-T cell therapy market. And. Thus, it surprises no one that investments are pouring in to support research and development in a massive way.

Global CAR-T Cell Therapy Market:  Regional Analysis

Europe and Asia Pacific will hold a substantial share of the global CAR-T Cell Therapy Market owing to increasing cases of leukemia. North America and Europe will also see growth owing to a large patient pool, better healthcare infrastructure and good levels of awareness. Besides, research and development programs are increasing like that for Kymriah, mentioned above.. And, approvals are also contributing positively to the growth of the global CAR-T cells market. This awareness levels are also seeing a steep upward curve in the Asia Pacific region, creating lucrative opportunities for players operating in the global CAR-T Cell Therapy market.

The market is segmented as presented below:

Target Antigen

  • CD19
  • CD20
  • MESO
  • HER2
  • EGFRV III

Application

  • Acute Lymphoblastic Leukemia
  • Diffuse Large B-Cell Lymphoma
  • Follicular Lymphoma
  • Chronic Lymphocytic Leukemia
  • Multiple Myeloma

The study presents a granular assessment and quantitative evaluation of:

  • Key growth factors and prominent trends
  • Size and share of key segments in overall market
  • Key challenges and winning imperatives
  • Factors shaping competitive landscape
  • Insights into how contours of market will change in coming years
  • Technological advances
  • New avenues and imminent investment pockets
  • Regulatory landscape shaping current and future strategies of companies

The region-wise assessment includes market dynamics in:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The study is prepared with the help of an extensive primary and secondary research. Primary research includes but not limited to interactions, interviews, surveys, and events. Opinions of policy makers and industry experts are carefully integrated into the insights to complement primary research. Volumes of secondary data gleaned through renowned paid sources, annual statements, reputed journals, and government documents offer insights into current dynamics and key evolution trajectories the market is likely to assume. The research employs various industry-wide analytics methods and well-established methodologies to ascertain the attractiveness of key segments. Further, it evaluates the lucrativeness of key regions and factors underlying their maturity. The insights notably include a detailed analysis of forces behind vendor differentiation and offers insight into investment-decision making by prominent players.

The report strives to enlighten businesses and industry stakeholders on multiple facets of the growth dynamic of the market, the key of which include answers to:

  • Which key factors will shape the competitive landscape?
  • Which trends will stimulate research and development activities in different geographies?
  • Which are the lucrative growth areas and what is the size of potential they are likely contribute to the overall market?
  • Which disruptions in market growth are likely to come with the new business models?
  • Which are some of the recent overhauls in policies that may change the course of the market significantly?
  • Which are the geographies that will form sizable sources of new streams to new and established players alike?
  • How are top players likely to realign their strategy to counter the forces of competition?
  • Which key strategies emerging players are likely to focus on to consolidate their position?
  • Which changes in end-user preferences might affect the status quo held by the leading players?
  • Which are some of the game-changing innovations influencing the projected share and revenue of the market and its segments?

Note: Utmost care has invariably been taken to present data and arrive at statistics at all the TMR Research reports. Meanwhile, some recent developments and new industry trends may take time to be included in the reports.